Corteva, Inc. $CTVA Shares Purchased by Qube Research & Technologies Ltd

Qube Research & Technologies Ltd raised its holdings in Corteva, Inc. (NYSE:CTVA) by 566.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,247,120 shares of the company’s stock after purchasing an additional 1,059,872 shares during the quarter. Qube Research & Technologies Ltd owned about 0.18% of Corteva worth $92,948,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in CTVA. Gladwyn Financial Advisors Inc. acquired a new position in Corteva in the 2nd quarter valued at about $25,000. Curat Global LLC grew its position in Corteva by 93.7% in the 2nd quarter. Curat Global LLC now owns 370 shares of the company’s stock valued at $28,000 after buying an additional 179 shares during the last quarter. Maryland Capital Advisors Inc. acquired a new position in Corteva in the 2nd quarter valued at $29,000. Twin Peaks Wealth Advisors LLC purchased a new position in Corteva during the 2nd quarter worth $29,000. Finally, DHJJ Financial Advisors Ltd. lifted its stake in shares of Corteva by 132.2% in the 2nd quarter. DHJJ Financial Advisors Ltd. now owns 527 shares of the company’s stock worth $39,000 after acquiring an additional 300 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Down 1.2%

Shares of CTVA stock opened at $65.03 on Thursday. The stock has a market cap of $43.94 billion, a P/E ratio of 27.79, a P/E/G ratio of 1.49 and a beta of 0.74. The company has a quick ratio of 1.07, a current ratio of 1.58 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $77.41. The business has a fifty day simple moving average of $64.17 and a 200-day simple moving average of $69.52.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, November 4th. The company reported ($0.23) EPS for the quarter, beating analysts’ consensus estimates of ($0.49) by $0.26. The firm had revenue of $2.62 billion for the quarter, compared to analysts’ expectations of $2.47 billion. Corteva had a net margin of 9.19% and a return on equity of 9.37%. The firm’s revenue was up 6.5% on a year-over-year basis. During the same period in the prior year, the company earned ($0.49) EPS. On average, analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Monday, December 1st will be paid a $0.18 dividend. The ex-dividend date of this dividend is Monday, December 1st. This represents a $0.72 dividend on an annualized basis and a yield of 1.1%. Corteva’s dividend payout ratio is presently 30.77%.

Analyst Ratings Changes

Several research analysts recently issued reports on CTVA shares. Rothschild & Co Redburn cut their price target on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a report on Tuesday, November 11th. Mizuho reduced their price target on Corteva from $85.00 to $78.00 and set an “outperform” rating for the company in a report on Wednesday, October 8th. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 30th. Argus cut their price objective on Corteva from $83.00 to $80.00 and set a “buy” rating for the company in a research report on Monday, October 13th. Finally, Wells Fargo & Company lowered their price target on shares of Corteva from $80.00 to $77.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 11th. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $78.05.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.